Document is current
Any future updates will be listed below
-
Authors
Jantawong, Chanakan
Chamgramol, Yaovalux
Intuyod, Kitti
Priprem, Aroonsri
Pairojkul, Chawalit
Klungsaeng, Sirinapha
Dangtakot, Rungtiwa
Pongking, Thatsanapong
Sitthirach, Chutima
Pinlaor, Porntip
Waraasawapati, Sakda
Pinlaor, Somchai
-
Funding
Funding for this research was provided by:
Cholangiocarcinoma Research Institute (CARI), Khon Kaen University, Khon Kaen, Thailand (CARI 02/2561)
Basic Research Fund of Khon Kaen University under Cholangiocarcinoma Research Institute (CARI-FF64-6)
Center of Excellence on Medical Biotechnology (CEMB), S&T Postgraduate Education and Research Development Office (PERDO), Office of Higher Education Commission (OHEC), Thailand (SN-59-002-05)
- License Information
-
More Information
Article History
Received: 3 April 2022
Accepted: 10 January 2023
First Online: 24 January 2023
Declarations
:
: This study protocol was reviewed and approved by the Animal Ethics Committee of Khon Kaen University (ACUC-KKU-59/2559), based on the ethical guidelines for Animal Experimentation of the National Research Council of Thailand.
: Not applicable.
: Welltech Biotechnology Co., Ltd, Thailand, the producer and supplier of CNCs and BNCs, had no part in the planning and conducting the experimental design in this project. The authors declare that they have no competing of interests.
